MXPA01010701A - Vaccine. - Google Patents

Vaccine.

Info

Publication number
MXPA01010701A
MXPA01010701A MXPA01010701A MXPA01010701A MXPA01010701A MX PA01010701 A MXPA01010701 A MX PA01010701A MX PA01010701 A MXPA01010701 A MX PA01010701A MX PA01010701 A MXPA01010701 A MX PA01010701A MX PA01010701 A MXPA01010701 A MX PA01010701A
Authority
MX
Mexico
Prior art keywords
vaccine
Prior art date
Application number
MXPA01010701A
Other languages
Spanish (es)
Inventor
Anthony Holder
Original Assignee
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9909072.2A external-priority patent/GB9909072D0/en
Application filed by Medical Res Council filed Critical Medical Res Council
Publication of MXPA01010701A publication Critical patent/MXPA01010701A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA01010701A 1999-04-20 2000-04-20 Vaccine. MXPA01010701A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9909072.2A GB9909072D0 (en) 1999-04-20 1999-04-20 Vaccine
US31181799A 1999-05-13 1999-05-13
CA002271451A CA2271451A1 (en) 1999-04-20 1999-05-25 Variant c-terminal fragment of plasmodium falciparum msp-1
PCT/GB2000/001558 WO2000063245A2 (en) 1999-04-20 2000-04-20 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant

Publications (1)

Publication Number Publication Date
MXPA01010701A true MXPA01010701A (en) 2003-08-20

Family

ID=27170966

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01010701A MXPA01010701A (en) 1999-04-20 2000-04-20 Vaccine.

Country Status (7)

Country Link
EP (1) EP1180120A2 (en)
JP (1) JP2002543774A (en)
CN (1) CN1372568A (en)
AU (1) AU779662B2 (en)
BR (1) BR0009823A (en)
MX (1) MXPA01010701A (en)
WO (1) WO2000063245A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7595191B2 (en) 2001-01-26 2009-09-29 The United States Of America As Represented By The Secretary Of The Army Isolation and purification of P. falciparum merozoite protein-142 vaccine
WO2002058727A2 (en) 2001-01-26 2002-08-01 Walter Reed Army Institute Of Research Recombinant plasmodium falciparum merozoite protein-1/42 vaccine
CN1176945C (en) * 2001-02-01 2004-11-24 中国人民解放军第二军医大学 Plasmodium fused antigen and its preparing process and usage
EP1497307B1 (en) 2002-04-01 2016-08-03 Walter Reed Army Institute of Research Recombinant p.falciparum merozoite protein-1 42 vaccine
WO2015056244A1 (en) * 2013-10-18 2015-04-23 Universidade Federal De Minas Gerais - Ufmg Kit and immunodiagnostic method for detecting anaemia caused by vivax malaria, synthetic peptides and uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2744724B1 (en) * 1996-02-14 2002-08-02 Pasteur Institut RECOMBINANT PROTEIN CONTAINING A C-TERMINAL FRAGMENT OF PROTEIN MSP-1 OF A PLASMODIUM INFECTIOUS TO MAN FOR THE PRODUCTION OF ANTI-MALARIA VACCINES

Also Published As

Publication number Publication date
BR0009823A (en) 2002-04-09
CN1372568A (en) 2002-10-02
EP1180120A2 (en) 2002-02-20
AU779662B2 (en) 2005-02-03
WO2000063245A9 (en) 2002-08-29
JP2002543774A (en) 2002-12-24
WO2000063245A3 (en) 2001-05-03
WO2000063245A2 (en) 2000-10-26
AU4133000A (en) 2000-11-02

Similar Documents

Publication Publication Date Title
IL145044A0 (en) Vaccine
HUS1300072I1 (en) Vaccine
HUP0202885A3 (en) Vaccines
ZA200200477B (en) 2-pyrazolin-5-ones.
HK1054384A1 (en) 4-Pyrimidinyl-n-acyl-l-phenylalanines.
ZA200202537B (en) Pour-on-formulations.
HK1053470A1 (en) 4-Pyridinyln-acyl-l-phenylalanines.
GB9901254D0 (en) Vaccines
GB9915204D0 (en) Vaccine
MXPA01010701A (en) Vaccine.
GB9906437D0 (en) Vaccine
GB9913327D0 (en) Vaccine
HK1031254A1 (en) Tachogragh.
GB9909072D0 (en) Vaccine
ZA200006160B (en) Vaccine.
ZA99872B (en) Vaccine.
GB9925619D0 (en) Vaccine
GB9917144D0 (en) Vaccine
GB9915106D0 (en) Vaccine
GB9915205D0 (en) Vaccine
GB9905511D0 (en) Vaccine
GB9916677D0 (en) Vaccine
GB9904412D0 (en) Vaccine
GB9927336D0 (en) Vaccine
GB9919260D0 (en) Vaccine